daleed....your right this was great news. I'm not sure why it really hasnt popped yet. this will make the company profitable by year end instead of cash break even which is what they were projecting. thats HUGE. the price went down 75 cents in one day on no news and then its been scratching its way back up to the $11 range where it was tradeding previously. IMO this news should have propelled it to the 11.50 to $12 range. oh well, all good time, this company has finally got its act together on two great drugs and next year they release the protocol for the third one.
It is a mixed blessing. It buys them time, if they miss their goal of being cash flow positive by years end. It is also is good sign that the financing was an option... belief in management, etc. I have heard no specific details of what this up front payment actually costs however. These kinds of arrangements are never that cheap... They better remain on track.